HealthStream, Inc. (NASDAQ:HSTM) was the target of a large decline in short interest during the month of February. As of February 28th, there was short interest totalling 389,525 shares, a decline of 36.0% from the February 15th total of 608,582 shares. Approximately 1.5% of the company’s stock are sold short. Based on an average daily trading volume, of 229,520 shares, the days-to-cover ratio is presently 1.7 days.

Shares of HealthStream (NASDAQ HSTM) opened at $24.56 on Thursday. HealthStream has a 12-month low of $21.15 and a 12-month high of $31.53. The company has a market cap of $800.36, a price-to-earnings ratio of 79.23, a P/E/G ratio of 5.58 and a beta of 0.83.

How to Become a New Pot Stock Millionaire

HealthStream (NASDAQ:HSTM) last released its quarterly earnings results on Tuesday, February 20th. The technology company reported $0.04 EPS for the quarter, beating the consensus estimate of $0.03 by $0.01. HealthStream had a net margin of 4.04% and a return on equity of 2.73%. The firm had revenue of $62.76 million during the quarter, compared to the consensus estimate of $61.98 million. analysts expect that HealthStream will post 0.28 earnings per share for the current year.

The firm also recently declared a special dividend, which will be paid on Tuesday, April 3rd. Investors of record on Tuesday, March 6th will be given a $1.00 dividend. The ex-dividend date is Monday, March 5th.

In other news, insider Jeffrey Doster sold 10,000 shares of the business’s stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $24.57, for a total transaction of $245,700.00. Following the completion of the sale, the insider now owns 45,235 shares in the company, valued at approximately $1,111,423.95. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director C Martin Harris sold 10,452 shares of the business’s stock in a transaction that occurred on Thursday, March 1st. The stock was sold at an average price of $24.06, for a total transaction of $251,475.12. The disclosure for this sale can be found here. Insiders have sold a total of 81,452 shares of company stock valued at $1,979,525 in the last 90 days. Insiders own 21.10% of the company’s stock.

A number of hedge funds have recently added to or reduced their stakes in the stock. BlackRock Inc. increased its stake in HealthStream by 3.9% in the 4th quarter. BlackRock Inc. now owns 3,364,652 shares of the technology company’s stock valued at $77,925,000 after buying an additional 127,152 shares during the period. Conestoga Capital Advisors LLC increased its stake in HealthStream by 17.2% in the 4th quarter. Conestoga Capital Advisors LLC now owns 1,755,050 shares of the technology company’s stock valued at $40,647,000 after buying an additional 257,400 shares during the period. Dimensional Fund Advisors LP increased its stake in HealthStream by 4.4% in the 3rd quarter. Dimensional Fund Advisors LP now owns 1,239,449 shares of the technology company’s stock valued at $28,966,000 after buying an additional 51,900 shares during the period. State Street Corp increased its stake in HealthStream by 4.4% in the 2nd quarter. State Street Corp now owns 616,851 shares of the technology company’s stock valued at $16,239,000 after buying an additional 25,912 shares during the period. Finally, Stephens Investment Management Group LLC increased its stake in HealthStream by 2.4% in the 3rd quarter. Stephens Investment Management Group LLC now owns 570,870 shares of the technology company’s stock valued at $13,341,000 after buying an additional 13,192 shares during the period. Hedge funds and other institutional investors own 70.97% of the company’s stock.

Several analysts have recently weighed in on HSTM shares. ValuEngine downgraded shares of HealthStream from a “hold” rating to a “sell” rating in a research report on Thursday, March 1st. Cantor Fitzgerald reiterated a “hold” rating and issued a $24.00 price target on shares of HealthStream in a research report on Monday, February 12th. Barrington Research reiterated a “buy” rating and issued a $32.00 price target on shares of HealthStream in a research report on Monday, February 26th. Zacks Investment Research upgraded shares of HealthStream from a “sell” rating to a “hold” rating in a research report on Wednesday, February 7th. Finally, William Blair reiterated an “outperform” rating on shares of HealthStream in a research report on Tuesday, February 13th. One research analyst has rated the stock with a sell rating, six have issued a hold rating and four have given a buy rating to the company’s stock. HealthStream presently has a consensus rating of “Hold” and a consensus price target of $25.86.

ILLEGAL ACTIVITY WARNING: This story was posted by Daily Political and is the sole property of of Daily Political. If you are accessing this story on another publication, it was illegally stolen and reposted in violation of US and international trademark and copyright law. The legal version of this story can be read at https://www.dailypolitical.com/2018/03/15/healthstream-inc-hstm-short-interest-update.html.

About HealthStream

HealthStream, Inc (HealthStream) provides workforce, patient experience and provider solutions for healthcare organizations. The Company operates in three segments: HealthStream Workforce Solutions, HealthStream Patient Experience Solutions and HealthStream Provider Solutions. HealthStream’s products and services are organized into three segments: Workforce Solutions, Patient Experience Solutions, and Provider Solutions.

Receive News & Ratings for HealthStream Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthStream and related companies with MarketBeat.com's FREE daily email newsletter.